Insmed Incorporated Stock Analysis & AI Score
Insmed Incorporated (INSM) has an ST Score of 56.5 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $196.33 price target (+61.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Insmed Incorporated (INSM) has an ST Score of 56.5 (B-), driven by its Sentiment (A+) and held back by its Financial Strength (D). Analysts rate it Buy with a $196.33 price target (+61.5% upside).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD
All factor grades
- SentimentA+
- ForecastA
- GrowthB
- ValuationB-
- MomentumB-
- ProfitabilityC-
- Financial StrengthD
- Piotroski4/9
Contact
INSM stock: frequently asked questions
What is INSM's ST Score?
Insmed Incorporated (INSM) has an ST Score of 56.5 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is INSM a buy, hold, or sell?
Analysts rate INSM a Buy, with a price target of $196.33 (+61.5% vs the current price). Our ST Score grades it B- (56.5/100). The ST Score is a data-driven signal, not a recommendation.
What are INSM's factor grades?
Valuation B-, Profitability C-, Financial Strength D, Momentum B-, Growth B, Forecast A, Sentiment A+.
What is INSM's valuation grade?
Insmed Incorporated (INSM) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is INSM's growth grade?
Insmed Incorporated (INSM) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is INSM's profitability grade?
Insmed Incorporated (INSM) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is INSM's financial strength grade?
Insmed Incorporated (INSM) earns a financial strength grade of D, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for INSM?
The average analyst price target for Insmed Incorporated (INSM) is $196.33 from 35 analysts, which is +61.5% versus the recent price of $121.55.
What is INSM's Piotroski score?
Insmed Incorporated (INSM) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.